Skip to main content

Table 1 Patient’s Baseline Characterization

From: The association of QTc prolongation with cardiovascular events in cancer patients taking tyrosine kinase inhibitors (TKIs)

n = 451

Patients not on TKI’s (n = 265)

P-Value

Patients on TKI’s (n = 186)

P-Value

Non-DM(n = 213)

DM(n = 52)

Non-DM(n = 148)

DM(n = 38)

Age (years)

62.92 ± 13.22

67.18 ± 9.72

0.0161

58.67 ± 12.95

61.81 ± 12.46

0.1930

Time between Visits (years)

3.08 ± 3.22

2.63 ± 3.21

0.3606

3.59 ± 3.35

3.23 ± 3.08

0.5271

Gender, n (%)

      

Male

116 (54.72)

30 (57.69)

0.6990

70 (48.28)

26 (68.42)

0.0269

Female

96 (45.28)

22 (42.31)

75 (51.72)

12 (31.58)

Race, n (%)

      

Caucasian

186 (88.15)

42 (80.77)

0.2134

125 (86.81)

24 (64.86)

0.0192

African American

12 (5.69)

5 (9.62)

8 (5.56)

6 (16.22)

Asian

4 (1.90)

0 (0.0)

4 (2.78)

3 (8.11)

Other

9 (4.27)

5 (9.62)

7 (4.86)

4 (10.81)

Ethnicity, n (%)

      

Non-Hispanic

196 (95.15)

48 (94.12)

0.7258

133 (93.66)

31 (91.18)

0.7035

Hispanic

10 (4.85)

3 (5.88)

9 (6.34)

3 (8.82)

Obesity, n (%)

      

BMI < 25

85 (41.26)

22 (42.31)

0.9837

61 (44.53)

12 (31.58)

0.1442

BMI 25–30

66 (32.04)

16 (30.77)

30 (21.90)

14 (36.84)

BMI ≥ 30

55 (26.70)

14 (26.92)

46 (33.58)

12 (31.58)

BMI

26.62 ± 6.71

26.86 ± 6.47

0.8125

27.25 ± 7.19

28.64 ± 7.50

0.3109

HbA1c

5.51 ± 0.53

7.40 ± 1.19

< 0.0001

5.41 ± 0.57

7.60 ± 1.28

< 0.0001

Hypertension, n(%)

      

No

99 (46.48)

23 (4.23)

0.7706

93 (62.84)

19 (50.0)

0.1492

Yes

114 (53.52)

29 (55.77)

 

55 (37.16)

19 (50.0)

 

Dyslipidemia, n(%)

      

No

164 (77.0)

33 (63.46)

0.0451

123 (83.11)

27 (71.05)

0.0934

Yes

49 (23.0)

19 (36.54)

25 (16.89)

11 (28.95)

Alcohol Use, n (%)

      

None

144 (67.61)

36 (69.23)

0.8831

103 (69.59)

27 (71.05)

0.7482

Monthly

28 (13.15)

6 (11.54)

 

14 (9.46)

2 (5.26)

 

Weekly

18 (8.45)

6 (11.54)

 

16 (10.81)

5 (13.16)

 

Daily

9 (4.23)

1 (1.92)

 

1 (0.68)

1 (2.63)

 

Abuse

14 (6.57)

3 (5.77)

 

14 (9.46)

3 (7.89)

 

Heart rate (BPM)

80.59 ± 20.36

84.67 ± 19.58

0.1849

83.26 ± 20.48

81.08 ± 20.89

0.5671

QTc (ms), 1st Visit

436.31 ± 30.66

437.10 ± 35.06

0.8817

436.70 ± 34.48

445.21 ± 36.82

0.2035

LVEF (%), 1st Visit

57.64 ± 12.85

57.44 ± 13.77

0.9329

59.13 ± 12.22

58.72 ± 10.83

0.8568

QTC (ms), 2nd Visit

471.89 ± 44.62

477.71 ± 53.25

0.4686

473.46 ± 53.99

474.29 ± 40.34

0.9167

LVEF(%), 2nd Visit

55.11 ± 15.21

45.50 ± 20.51

0.6263

60.23 ± 14.12

56.00 ± 27.07

0.8137